HK1047243A1 - 預防性和治療性治療鏈球菌感染的方法 - Google Patents

預防性和治療性治療鏈球菌感染的方法 Download PDF

Info

Publication number
HK1047243A1
HK1047243A1 HK02108859.1A HK02108859A HK1047243A1 HK 1047243 A1 HK1047243 A1 HK 1047243A1 HK 02108859 A HK02108859 A HK 02108859A HK 1047243 A1 HK1047243 A1 HK 1047243A1
Authority
HK
Hong Kong
Prior art keywords
composition
carrier
enzyme
streptococcal
nasal
Prior art date
Application number
HK02108859.1A
Other languages
English (en)
Chinese (zh)
Inventor
Fischetti Vincent
Loomis Lawrence
Original Assignee
新眼界诊断公司
新眼界診斷公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 新眼界诊断公司, 新眼界診斷公司 filed Critical 新眼界诊断公司
Publication of HK1047243A1 publication Critical patent/HK1047243A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK02108859.1A 1999-02-25 1999-02-25 預防性和治療性治療鏈球菌感染的方法 HK1047243A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1999/004063 WO2000050069A1 (en) 1999-02-25 1999-02-25 A means for the prophylactic and therapeutic treatment of streptococcal infections
US09/257,025 US6017528A (en) 1997-10-31 1999-02-25 Therapeutic treatment of group A streptococcal infections

Publications (1)

Publication Number Publication Date
HK1047243A1 true HK1047243A1 (zh) 2003-02-14

Family

ID=26795447

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02108859.1A HK1047243A1 (zh) 1999-02-25 1999-02-25 預防性和治療性治療鏈球菌感染的方法

Country Status (12)

Country Link
US (1) US6017528A (enExample)
EP (1) EP1162994A4 (enExample)
JP (1) JP2002537350A (enExample)
KR (1) KR20020000217A (enExample)
AU (1) AU2876799A (enExample)
BR (1) BR9917152A (enExample)
CA (1) CA2366712A1 (enExample)
HK (1) HK1047243A1 (enExample)
IN (1) IN2001DE00791A (enExample)
MX (1) MXPA01008701A (enExample)
NZ (1) NZ514260A (enExample)
WO (1) WO2000050069A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232576B2 (en) 1997-10-31 2007-06-19 New Horizons Diagnostics Corp Throat lozenge for the treatment of Streptococcus Group A
US6277399B1 (en) 1997-10-31 2001-08-21 New Horizon Diagnostics Corporation Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections
US6432444B1 (en) * 1997-10-31 2002-08-13 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymes for treating dermatological infections
US6428784B1 (en) * 1997-10-31 2002-08-06 New Horizons Diagnostics Corp Vaginal suppository for treating group B Streptococcus infection
US6335012B1 (en) 1997-10-31 2002-01-01 Vincent Fischetti Use of bacterial phage associated lysing enzymes for treating bacterial infections of the mouth and teeth
US6399097B1 (en) 1997-10-31 2002-06-04 New Horizons Diagnostics Corporation Composition for treatment of a bacterial infection of the digestive tract
US20030129147A1 (en) * 1997-10-31 2003-07-10 Vincent Fischetti Use of bacterial phage associated lysing proteins for treating bacterial dental caries
US20020136712A1 (en) * 1997-10-31 2002-09-26 Fischetti Vincent Bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of colonization and infections caused by streptococcus pneumoniae
US20030129146A1 (en) * 1997-10-31 2003-07-10 Vincent Fischetti The use of bacterial phage associated lysing proteins for treating bacterial dental caries
US6423299B1 (en) 1997-10-31 2002-07-23 Vincent Fischetti Composition for treatment of a bacterial infection of an upper respiratory tract
US6056954A (en) * 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US6399098B1 (en) 1997-10-31 2002-06-04 New Horizons Diagnostics Corp Composition for treating dental caries caused by streptococcus mutans
US20030082110A1 (en) * 1997-10-31 2003-05-01 Vincent Fischetti Use of bacterial phage associated lysing proteins for treating bacterial dental caries
US6248324B1 (en) 1997-10-31 2001-06-19 Vincent Fischetti Bacterial phage associated lysing enzymes for treating dermatological infections
US6752988B1 (en) * 2000-04-28 2004-06-22 New Horizons Diagnostic Corp Method of treating upper resiratory illnesses
US6406692B1 (en) * 1997-10-31 2002-06-18 New Horizons Diagnostics Corp Composition for treatment of an ocular bacterial infection
US6326002B1 (en) 1997-10-31 2001-12-04 New Horizons Diagnostics Corporation Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract
US7063837B2 (en) * 1999-09-14 2006-06-20 New Horizons Diagnostics Corp Syrup composition containing phage associated lytic enzymes
US20020127215A1 (en) * 1999-09-14 2002-09-12 Lawrence Loomis Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
AU2001259205A1 (en) * 2000-04-28 2001-11-12 New Horizons Diagnostic Corporation The use of bacterial phage associated lysing enzymes for treating various illnesses
AU2001263408A1 (en) 2000-05-23 2001-12-03 The Rockefeller University C1 bacteriophage lytic system
US6395504B1 (en) 2000-09-01 2002-05-28 New Horizons Diagnostics Corp. Use of phage associated lytic enzymes for the rapid detection of bacterial contaminants
CA2427928A1 (en) * 2000-11-02 2002-12-27 New Horizons Diagnostics Corporation The use of bacterial phage associated lytic enzymes to prevent food poisoning
US20040213765A1 (en) * 2001-07-13 2004-10-28 Vincent Fischetti Use of bacterial phage associated lytic enzymes to prevent food poisoning
GB0118009D0 (en) * 2001-07-24 2001-09-19 Regma Biotechnologies Ltd Novel preparation
US6759229B2 (en) * 2001-12-18 2004-07-06 President & Fellows Of Harvard College Toxin-phage bacteriocide antibiotic and uses thereof
WO2004020451A1 (en) * 2002-08-29 2004-03-11 The Uab Research Foundation Group b streptococcal phage lysin
US7569223B2 (en) * 2004-03-22 2009-08-04 The Rockefeller University Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions
CA2833409A1 (en) 2011-04-21 2012-10-26 The Rockefeller University Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
DK3369742T3 (da) 2011-10-05 2020-10-19 Univ Rockefeller Dimere bakteriofaglysiner
JP6608697B2 (ja) 2012-05-09 2019-11-20 コントラフェクト コーポレイション グラム陽性菌に対するバクテリオファージ溶解素と抗生物質との組み合わせ
RU2646102C2 (ru) 2012-05-09 2018-03-01 Контрафект Корпорейшн Предотвращение, разрушение и обработка биопленки лизином бактериофага
KR101723466B1 (ko) 2015-10-08 2017-04-06 주식회사 인트론바이오테크놀로지 신규한 스트렙토코커스 이니에 박테리오파지 Ｓｔｒ-ＩＮＰ-1 및 이의 스트렙토코커스 이니에 균 증식 억제 용도
DK3454888T3 (da) 2016-05-12 2021-04-26 Contrafect Corp Bouillon-mikrofortyndingsfremgangsmåde til evaluering og bestemmelse af minimal inhibitorisk koncentration for antibakterielle polypeptider
WO2018011660A1 (en) 2016-07-11 2018-01-18 Philip Morris Products S.A. Hydrophobic capsule
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852424A (en) * 1957-07-26 1974-12-03 Ciba Geigy Corp Purified ferrimycin and process for obtaining same
AU8108587A (en) * 1986-10-08 1988-05-06 David Bernstein Method for exposing group a streptococcal antigens and an improved diagnostic test for the identification of group a streptococci
US5997862A (en) * 1997-10-31 1999-12-07 New Horizons Diagnostics Corporation Therapeutic treatment of group A streptococcal infections

Also Published As

Publication number Publication date
JP2002537350A (ja) 2002-11-05
CA2366712A1 (en) 2000-08-31
BR9917152A (pt) 2002-11-26
NZ514260A (en) 2003-02-28
WO2000050069A1 (en) 2000-08-31
IN2001DE00791A (enExample) 2007-05-25
US6017528A (en) 2000-01-25
MXPA01008701A (es) 2003-06-24
EP1162994A4 (en) 2004-12-29
KR20020000217A (ko) 2002-01-05
EP1162994A1 (en) 2001-12-19
AU2876799A (en) 2000-09-14

Similar Documents

Publication Publication Date Title
HK1047243A1 (zh) 預防性和治療性治療鏈球菌感染的方法
US5997862A (en) Therapeutic treatment of group A streptococcal infections
US6056955A (en) Topical treatment of streptococcal infections
US6254866B1 (en) Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract
US6056954A (en) Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US7169408B2 (en) Bandage composition containing phage associated lytic enzymes useful for treating dermatological infections
US6326002B1 (en) Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract
CN104010653A (zh) 用于预防并治疗口腔疾病的组合物和方法
US6899874B2 (en) Method for the treatment of bacterial vaginal infections
US6399097B1 (en) Composition for treatment of a bacterial infection of the digestive tract
US7141241B2 (en) Use of bacterial phage associated lysing enzymes for treating upper respiratory illnesses
US6733749B2 (en) Throat lozenges for the treatment of Hemosphilus influenza
RU2104710C1 (ru) Фармацевтические бактериоциновые композиции и их применение
US6752988B1 (en) Method of treating upper resiratory illnesses
CN1327854A (zh) 一种溶葡萄球菌复合酶口腔喷雾剂及制备方法
HANDSFIELD et al. Treatment of Uncomplica fed Gonorrhea with Cefotaxime
RU2239451C2 (ru) Способ терапевтического или профилактического лечения стрептококковых инфекций (варианты) и композиция, предназначенная для использования в нем (варианты), лизиновый фермент, ассоциированный с фагом стрептококков группы с,- активный агент фармацевтической композиции
CN1352567A (zh) 预防性和治疗性治疗链球菌感染的方法
AU2005200385A1 (en) A means for the prophylactic and therapeutic treatment of streptococcal infections
US7232576B2 (en) Throat lozenge for the treatment of Streptococcus Group A
CN120754078A (zh) 亚油酸在制备提高革兰氏阳性菌对抗生素敏感性药物中的应用